Citizens Maintains Market Outperform on Pharvaris, Raises Price Target to $75
Pharvaris N.V.
Pharvaris N.V. PHVS | 0.00 |
Citizens analyst Jonathan Wolleben maintains Pharvaris (NASDAQ:
PHVS) with a Market Outperform and raises the price target from $74 to $75.
